News & Resources

SEC Filings

<< Back
Form 424B5
OREXIGEN THERAPEUTICS, INC. filed this Form 424B5 on 03/30/2017
Document Outline
Entire Document (352.1 KB)
Subdocument 1 - 424B5 - 424B5
Page 1 - Filed Pursuant to Rule 424(b)(5)
Page 2 - TABLE OF CONTENTS
Page 3 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 4 - PROSPECTUS SUPPLEMENT SUMMARY
Page 5 - Company Information
Page 6 - RISK FACTORS
Page 7 - FORWARD-LOOKING STATEMENTS
Page 8 - N/A
Page 9 - USE OF PROCEEDS
Page 10 - DILUTION
Page 11 - PLAN OF DISTRIBUTION
Page 12 - LEGAL MATTERS
Page 13 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 14 - Prospectus
Page 15 - TABLE OF CONTENTS
Page 16 - N/A
Page 17 - PROSPECTUS SUMMARY
Page 18 - Company Information
Page 19 - THIS PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PRO
Page 20 - Debt Securities.
Page 21 - RISK FACTORS
Page 22 - FINANCIAL RATIOS
Page 23 - DESCRIPTION OF CAPITAL STOCK
Page 24 - N/A
Page 25 - Effect of Certain Provisions of our Certificate of Incorporation and Bylaws and the Delaware Anti-Ta
Page 26 - Delaware Law
Page 27 - Certain Registration Obligations
Page 28 - DESCRIPTION OF DEBT SECURITIES
Page 29 - N/A
Page 30 - Conversion or Exchange Rights
Page 31 - Modification of Indenture; Waiver
Page 32 - Discharge
Page 33 - Form, Exchange and Transfer
Page 34 - Payment and Paying Agents
Page 35 - General
Page 36 - Governing Law
Page 37 - Street Name Holders
Page 38 - Global Securities
Page 39 - Special Situations When a Global Security Will Be Terminated
Page 40 - N/A
Page 41 - LEGAL MATTERS
Page 42 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 43 - Common Stock